Skip to main content
Molecular Partners AG (MLLCF)
OTCMKTS · Delayed Price · Currency is USD
4.220
-0.060 (-1.40%)
At close: Jan 30, 2025

Molecular Partners AG Revenue

In the year 2024, Molecular Partners AG had annual revenue of 4.97M CHF, down -29.38%.

Revenue
4.97M CHF
Revenue Growth
-29.38%
P/S Ratio
28.18
Revenue / Employee
31.36K CHF
Employees
159
Market Cap
154.57M USD

Revenue Chart

* This company reports financials in CHF.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20244.97M-2.07M-29.38%
Dec 31, 20237.04M-182.56M-96.29%
Dec 31, 2022189.60M179.85M1,843.82%
Dec 31, 20219.75M410.00K4.39%
Dec 31, 20209.34M-11.04M-54.16%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SS Innovations International 20.65M
Endo Inc. 1.76B
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
Glass House Brands 200.90M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Molecular Partners AG News

More News